Sunil Healthcare Ltd
Sunil Healthcare Ltd (SUNLOC) last reported results for the quarter ended Jun 2026, with sales of ₹18.99 crore and net profit of ₹0.46 crore. The stock last traded at ₹68, a market capitalisation of ₹69.7 crore, on a P/E of 18.9. Over the past 52 weeks the stock has ranged between ₹56.4 and ₹82.3. Figures are as of 6 Oct 2026 and are not real time.
Sunil Healthcare Ltd share price and key metrics
- Current price
- ₹68
- Market cap
- ₹69.7 cr
- Stock P/E
- 18.9
- Book value
- ₹67.9
- ROE
- 6.01%
- ROCE
- 6.43%
- Dividend yield
- 0.00%
- 52w high / low
- 82.3/56.4
Metrics as of 6 Oct 2026. Not real time.
Track Sunil Healthcare Ltd
Cruxal reads every Sunil Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Sunil Healthcare Ltd growth and returns
- 10 Years
- %
- 5 Years
- -1%
- 3 Years
- -7%
- TTM
- -1%
- 10 Years
- %
- 5 Years
- 55%
- 3 Years
- -15%
- TTM
- 1950%
- 10 Years
- -2%
- 5 Years
- 9%
- 3 Years
- 9%
- 1 Year
- -15%
- 10 Years
- 3%
- 5 Years
- 5%
- 3 Years
- 1%
- Last Year
- 6%
Sunil Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹18.99 cr, down 16.1% from ₹22.64 cr a year earlier. Net profit was ₹0.46 cr, down 49.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 20.26 | 20.46 | 21.2 | 22.64 | 23.52 | 21.84 | 19.72 | 18.99 |
| Expenses | 17.95 | 17.76 | 18.17 | 19.37 | 19.59 | 18.22 | 17.78 | 16.06 |
| Operating profit | 2.31 | 2.7 | 3.03 | 3.27 | 3.93 | 3.62 | 1.94 | 2.93 |
| OPM % | 11.40% | 13.20% | 14.29% | 14.44% | 16.71% | 16.58% | 9.84% | 15.43% |
| Other income | 0.18 | 0.53 | 0.49 | 0.86 | 0.42 | 0.5 | 0.29 | 0.23 |
| Interest | 1.5 | 1.89 | 1.56 | 1.44 | 1.4 | 1.66 | 1.66 | 1.5 |
| Depreciation | 1.51 | 1.69 | 1.68 | 1.66 | 1.64 | 1.62 | 1.52 | 1.46 |
| Profit before tax | -0.52 | -0.35 | 0.28 | 1.03 | 1.31 | 0.84 | -0.95 | 0.2 |
| Tax % | 7.69% | 57.14% | -28.57% | 11.65% | 23.66% | 30.95% | -258.95% | -130.00% |
| Net profit | -0.55 | -0.54 | 0.36 | 0.91 | 1 | 0.59 | 1.52 | 0.46 |
| EPS (₹) | -0.54 | -0.53 | 0.35 | 0.89 | 0.98 | 0.58 | 1.48 | 0.45 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Sunil Healthcare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108 | 91.33 | 80.88 | 70.02 | 90.62 | 119 | 110 | 90.19 | 83.42 | 87.72 | 84.07 |
| Operating profit | 15.15 | 13.89 | 11.26 | -6.93 | 5.35 | 17.38 | 16.17 | 4.26 | 10.36 | 12.77 | 12.42 |
| OPM % | 13.97% | 15.21% | 13.92% | -9.90% | 5.90% | 14.59% | 14.63% | 4.72% | 12.42% | 14.56% | 14.77% |
| Net profit | 5.03 | 4.49 | -0.69 | -4.96 | -0.64 | 6.42 | 6.68 | -1.79 | -1.42 | 4.01 | 3.57 |
| EPS (₹) | 4.91 | 4.38 | -0.67 | -4.84 | -0.62 | 6.26 | 6.51 | -1.75 | -1.38 | 3.91 | 3.49 |
TTM is the trailing twelve months to the most recent quarter.
Sunil Healthcare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves | 32.65 | 37.18 | 36.52 | 34.34 | 33.46 | 39.70 | 45.74 | 57.96 | 56.81 | 59.35 |
| Borrowings | 44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.15 | 68.65 | 59.37 |
| Other liabilities | 31.41 | 34.16 | 35.88 | 36.19 | 27.03 | 25.06 | 28.01 | 24.13 | 26.23 | 35.53 |
| Total liabilities | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.49 | 161.94 | 164.50 |
| Fixed assets | 59.72 | 70.92 | 68.83 | 69.97 | 69.80 | 69.97 | 70.43 | 87.16 | 94.08 | 85.85 |
| CWIP | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.09 | 1.77 |
| Investments | 0.00 | 0.10 | 0.11 | 0.11 | 1.07 | 1.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 59.00 | 71.00 | 66.32 | 60.14 | 49.68 | 36.94 | 50.35 | 65.67 | 67.77 | 76.88 |
| Total assets | 118.84 | 142.21 | 137.73 | 130.23 | 120.56 | 109.69 | 120.79 | 158.49 | 161.94 | 164.50 |
As reported by the company. Total assets equal total liabilities by construction.
Sunil Healthcare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 10.79 | 5.48 | 14.73 | 4.31 | 16.99 | 22.51 | 7.47 | -15.40 | 11.52 | 22.15 |
| Cash from investing | -12.85 | -17.18 | -2.80 | -2.52 | -11.36 | -4.24 | -3.40 | -10.11 | -7.70 | -2.85 |
| Cash from financing | 2.23 | 11.02 | -11.63 | -1.56 | -6.42 | -18.56 | -3.75 | 25.00 | -3.87 | -19.26 |
| Net cash flow | 0.17 | -0.67 | 0.30 | 0.23 | -0.79 | -0.29 | 0.32 | -0.51 | -0.05 | 0.04 |
| Free cash flow | -2.15 | -10.13 | 9.22 | 3.63 | 10.28 | 13.49 | 3.99 | -25.58 | 2.52 | 18.60 |
| CFO / operating profit | 82% | 50% | 134% | -64% | 315% | 136% | 55% | -344% | 111% | 175% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Sunil Healthcare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 11.60% | 5.43% | 1.65% | 5.12% | 14.25% | 15.30% | 2.98% | 3.96% | 6.43% |
| Debtor days | 129.57 | 192.39 | 177.08 | 122.81 | 94.37 | 57.86 | 93.85 | 164.27 | 182.19 | 187.78 |
| Inventory days | 76.09 | 101.63 | 213.19 | 322.80 | 117.09 | 83.25 | 105.15 | 110.57 | 171.70 | 208.60 |
| Days payable | 138.91 | 180.29 | 294.23 | 292.81 | 109.16 | 65.01 | 114.04 | 47.85 | 86.82 | 177.88 |
| Cash conversion cycle | 66.75 | 113.73 | 96.04 | 152.81 | 102.30 | 76.09 | 84.96 | 226.99 | 267.07 | 218.51 |
| Working capital days | -11.68 | -16.43 | -50.91 | -63.65 | -53.49 | -25.91 | -4.33 | 6.35 | -2.54 | 21.60 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Sunil Healthcare Ltd shareholding pattern
Promoters held 73.53% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.10%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% |
| DIIs | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
| Public | 26.36% | 26.37% | 26.36% | 26.38% | 26.37% | 26.36% | 26.37% | 26.37% |
| No. of shareholders | 6,507 | 6,550 | 6,541 | 6,475 | 6,430 | 6,399 | 6,364 | 6,310 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Sunil Healthcare Ltd corporate filings
- Compliance certificate for the quarter ended 30.09.2026 under regulation 74(5) of SEBI (DP) RegulationsCompany Updatelow impact
- Sunil Healthcare Limited's Credit Rating Upgraded by Brickwork Ratings, Long-term rating revised to BWRBBB- from CARE BB+Company Updatehigh impact
Cruxal's analysis: Sunil Healthcare Limited has received an upgrade in its credit ratings from Brickwork…
Read the full analysis - Voting Results and Scrutinizers Report dated 29.09.2026 of 52nd AGM of Sunil Healthcare Limited held on Monday, 28th September 2026 at 12.30 P.M.AGM/EGMmedium impact
- Sunil Healthcare Limited concludes 52nd Annual General Meeting; management highlights focus on operational efficiency and cost controlAGM/EGMlow impact
Cruxal's analysis: Sunil Healthcare Limited has successfully concluded its 52nd Annual General Meeting held…
Read the full analysis - Trading window of the Company shall remain close from October 01, 2026 till 48 hours of the declaration of un-audited financial results for the 2nd quarter/half year of FY 2026-27 ending on 30.09.2026Insider Trading / SASTlow impact
- Sunil Healthcare Limited announces schedule for 52nd Annual General Meeting and e-voting cut-off dateCorp. Actionlow impact
Cruxal's analysis: Sunil Healthcare Limited has formally notified the stock exchanges regarding the…
Read the full analysis - Sunil Healthcare Limited Announces 52nd AGM Date and Book Closure for FY 2025-26Company Updatelow impact
Cruxal's analysis: Sunil Healthcare Limited has formally intimated the scheduling of its 52nd Annual General…
Read the full analysis - Sunil Healthcare Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Sunil Healthcare Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Sunil Healthcare Limited Announces 52nd Annual General Meeting for September 28, 2026AGM/EGMlow impact
Cruxal's analysis: Sunil Healthcare Limited has issued a notice for its 52nd Annual General Meeting (AGM) to…
Read the full analysis - Sunil Healthcare Ltd announces newspaper publication for shareholder email updation ahead of 52nd AGMCompany Updatelow impact
Cruxal's analysis: Sunil Healthcare Ltd has published a notice in newspapers to facilitate the updation of…
Read the full analysis - Sunil Healthcare Limited Reports Unaudited Financial Results for Q1 FY 2026-27Company Updatelow impact
Cruxal's analysis: Sunil Healthcare Limited has released its unaudited financial results for the first…
Read the full analysis - Sunil Healthcare Limited Reports Q1 FY27 Financial Results with Return to ProfitabilityBoard Meetinghigh impact
Cruxal's analysis: Sunil Healthcare Limited reported a turnaround in Q1 FY27, achieving a standalone net…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.